OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

CFO exercised or converted 4,938 HIMS derivative securities | OQRO

Home
Insider trades
Hims & Hers Health
CFO exercised or converted 4,938 HIMS derivative securities

Insider trades

Insider trade

CFO exercised or converted 4,938 HIMS derivative securities

Traded Aug 19, 2026 · Filed Aug 20, 2026

HIMHims & Hers HealthHIMS

4,938
Shares · @ $5.01

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 19, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 20, 2026

CFOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001907056-26-000022

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Aug 20, 2026, 8:30 PM UTC

Added to OQRO

Oct 6, 2026, 7:59 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Hims & Hers Health, Inc.

Issuer CIK

1773751

Ticker

HIMS

Reporting person

Oluyemi Okupe

Relationship

Officer

Officer title

Chief Financial Officer

Security

Class A Common Stock

Table

Non-derivative (Table I)

Transaction date

Aug 19, 2026

Transaction code

Shares / units

4,938

Price per share

$5.01

Acquired / disposed

Acquired (A)

Shares owned after

269,055

Ownership form

Direct

Amendment

Footnotes from the filing

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Around the same time

Oluyemi Okupe (Chief Financial Officer) sold ~$355K of Hims & Hers Health

Scheduled in advanceFiled 3w ago

Soleil Boughton (Chief Legal Officer) sold ~$174K of Hims & Hers Health

Scheduled in advanceFiled 3w ago

Michael Chi (Chief Operating Officer) sold ~$398K of Hims & Hers Health

Scheduled in advanceFiled 3w ago